Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01084785 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biobank Carcinoma: Storing Blood and Protein of Patients With Cancer

Study acronym: Biobank
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 13, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Jan 2026 to May 1, 2026 Start date: Jan 2003 to Jan 1, 2003v11 Show 1 more changeShow less
    • Start date: Jan 2003 to Jan 1, 2003
  2. Primary and study completion dates: Jan 2025 to Jan 2026v10
  3. 7 versions Re-verified since Sep 21, 2010, no change to tracked fieldsv3-v9
  4. Eligibility criteria revisedv2 See this version in full on ClinicalTrials.gov ↗
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine, by means of DNA and protein analysis, the relationship between DNA and protein profiles and a number of endpoints, which are important for the patient such as overall survival and side effects.
Trial Details
NCT Number NCT01084785
Lead Sponsor Maastricht Radiation Oncology
Collaborators: Maastricht University Medical Center
Conditions Cancer
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov